Home / News
-
-
On October 20, Sansure Biotech disclosed 2022 third quarter report, the company achieved revenue of CNY 4.068 billion in three quarters this year, an increase of 24.52% year-on-year; the net profit attributable to the mother achieved CNY 1.598 billion.2022-10-22View More
-
-
Danaher on Thursday reported a 6 percent year-over-year increase in third quarter revenues as its subsidiaries see shifting demand for COVID-19-related products, such as diagnostic tests and pharmaceuticals.2022-10-21View More
-
-
Avacta, a UK-based developer of cancer immunotherapies and diagnostics, said on Tuesday that it has signed an agreement to acquire Launch Diagnostics for up to ¡ê37 million ($41.9 million).2022-10-21View More
-
-
Pointe Biotech (Nanjing) Co., Ltd. (hereinafter referred to as: Pointe) and its shareholders formally reached a strategic consensus and completed the signing of the contract2022-10-20View More
-
-
The company raised its earnings forecast for 2022 on estimates of $7.8 billion in annual sales related to COVID-19 testing.2022-10-20View More
-
-
Roche¡¯s third-quarter results have revealed a clear sign that the bumper sales boosting companies that have provided products to diagnose, treat or prevent COVID-19 since the start of the pandemic are starting to tail off.2022-10-20View More
-
-
Becton Dickinson announced on Tuesday a collaboration with Magnolia Medical Technologies, under which the firms will co-sell and comarket the Magnolia Medical Steripath and Steripath Micro Initial Specimen Diversion Device, which complement the BD Vacutainer specimen collection portfolio.2022-10-19View More
-
-
Illumina said on Tuesday that it has partnered with French company GenoScreen on genomic testing for multidrug-resistant tuberculosis.2022-10-19View More
-
-
On October 15, the General Office of Hangzhou Municipal People's Government issued the "Notice on Several Measures to Accelerate the High-Quality Development of Biomedical Industry"2022-10-18View More
-
-
Biodesix said Monday that it has been awarded a US Federal Supply Schedule contract for cancer testing of covered patients served by the Veterans Health Administration and Military Health System.2022-10-18View More
-
-
PBD Biotech said Monday it gained investment funding of ¡ê2.4 million ($2.7 million) to support clinical trials for its Actiphage rapid screening test for latent tuberculosis infections and their potential to develop into serious disease.2022-10-18View More
-
-
Since October, companies in the pharmaceutical field have successively announced monthly forecasts for the first three quarters.2022-10-17View More
-
-
Canadian diagnostics firm MedMira said on Friday that its Vyra COVID-19 Antigen Test has been CE marked and is now available in countries that accept the designation.2022-10-17View More
-
-
National Health Service England on Wednesday published a five-year strategy on accelerating the adoption of genomics into the British healthcare system. The new strategy places genomics at the heart of a new effort to deliver a sustainable model of healthcare for patients.2022-10-17View More
-
-
On October 13, 2022, the Shenzhen Stock Exchange disclosed that the 73rd Review Meeting of the GEM Listing Committee in 2022 was held and approved Jiaxing Quaero Life Science Co., Ltd. to be listed on the Sci-Tech Innovation Board.2022-10-14View More
-
-
Standard BioTools ¡ª formerly Fluidigm ¡ª said on Thursday that its Biomark and Juno molecular diagnostic systems have received approval from China's National Medical Products Administration.2022-10-14View More
-
-
GE published a regulatory filing about the spinoff of its healthcare unit, which it expects to complete in the first week of 2023, if the transaction is approved by its board of directors. GE HealthCare will be listed on the Nasdaq under the ticker ¡°GEHC.¡±2022-10-14View More
-
-
QuidelOrtho on Wednesday reported preliminary third quarter revenues of between $782 million and $785 million.2022-10-13View More
-
-
Illumina said on Tuesday that it has entered into a strategic research collaboration with AstraZeneca on drug target discovery.2022-10-13View More
-
-
Amoy (300685.SZ) and Beigene (NASDAQ: BGNE, HKEX: 06160, SSE: 688235) have recently entered into a strategic collaboration on companion diagnostics.2022-10-12View More
- CAIVD WeChat
Subscription Account
- CAIVD WeChat
Channels
China Association of In-vitro Diagnostics
Part of the information in our website is from the internet.
If by any chance it violates your rights, please contact us.